SCHEMBL4599141

SCHEMBL4599141

O=C(Oc1cccc(OCc2ccccc2)c1)N1CCOCC1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.70
ALDH1A1 P00352 1/20 0.70
EPHX1 P07099 2/20 0.67
KMT2A Q03164 5/20 0.60
MEN1 O00255 3/20 0.60
NPSR1 Q6W5P4 2/20 0.60
RAB9A P51151 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
KDM4E B2RXH2 2/20 0.56
NPC1 O15118 1/20 0.56
ADORA2A P29274 1/20 0.55
ADORA1 P30542 1/20 0.55
TSHR P16473 1/20 0.54
CASP3 P42574 1/20 0.54
SENP7 Q9BQF6 1/20 0.54
LMNA P02545 1/20 0.53
MAPT P10636 1/20 0.53
HPGD P15428 1/20 0.53
HTT P42858 1/20 0.53
TP53 P04637 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5648270 0.88 KMT2A (0.68) HSD17B10ALDH1A1EPHX1KMT2AMEN1
SCHEMBL28562874 0.82 KMT2A (0.66) HSD17B10ALDH1A1EPHX1KMT2AMEN1
SCHEMBL5101418 0.81 KMT2A (0.82) HSD17B10EPHX1KMT2AMEN1NPSR1
SCHEMBL4197062 0.80 EPHX1 (1.00) HSD17B10ALDH1A1EPHX1KMT2AMEN1
SCHEMBL16774417 0.80 HSD17B10 (0.63) HSD17B10EPHX1KMT2AMEN1NPSR1
SCHEMBL31669318 0.79 SPHK1 (0.51) ALDH1A1KDM4ELMNAHTT
SCHEMBL9472899 0.79 RAB9A (0.62) HSD17B10EPHX1KMT2AMEN1NPSR1
SCHEMBL5653626 0.78 KMT2A (0.72) HSD17B10EPHX1KMT2AMEN1NPSR1
SCHEMBL28749468 0.78 ALDH1A1 (0.54) ALDH1A1KMT2AMEN1KDM4ENAAA
SCHEMBL1337663 0.77 KMT2A (0.97) ALDH1A1KMT2AMEN1NPSR1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP claimed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO claimed
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP disclosed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO disclosed